Search Results - "YASUTO MATSUO"

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study by Shimoda, Seiya, Sakamoto, Wakana, Hokamura, Ayaka, Matsuo, Yasuto, Sekigami, Taiji, Ichimori, Shinji, Iwashita, Shinsuke, Ishii, Norio, Otsu, Kae, Yoshimura, Ryohei, Nishiyama, Toshihiko, Sakaguchi, Masaji, Nishida, Kenro, Araki, Eiichi

“…To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs (insulin…”
Get full text

Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy by Shimoda, Seiya, Iwashita, Shinsuke, Ichimori, Shinji, Matsuo, Yasuto, Goto, Rieko, Maeda, Takako, Matsuo, Tomoko, Sekigami, Taiji, Kawashima, Junji, Kondo, Tatsuya, Matsumura, Takeshi, Motoshima, Hiroyuki, Furukawa, Noboru, Nishida, Kenro, Araki, Eiichi

“…To assess the efficacy and safety of adding sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in subjects with type 2 diabetes inadequately controlled…”
Get full text

A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study) by Shimoda, Seiya, Sato, Miki, Sekigami, Taiji, Motoshima, Hiroyuki, Yoshimura, Ryohei, Fukuda, Kazuki, Matsuo, Yasuto, Noda, Hideyuki, Okubo, Mina, Ichimori, Shinji, Fujisawa, Kazuo, Fukunaga, Makiko, Araki, Eiichi, Nishikawa, Takeshi, Furukawa, Noboru, Matsumura, Takeshi, Kondo, Tatsuya, Kawashima, Junji, Senokuchi, Takafumi, Igata, Motoyuki, Nishida, Kenro, Yano, Tomohiko, Taguchi, Tetsuya, Matsuda, Hirofumi, Tsuruzoe, Kaku, Hirashima, Yoshiaki, Kaneko, Kengo, Kitanao, Sayaka, Hazekawa, Iwaho, Ebihara, Kenji, Murata, Yusuke, Watanabe, Eiichiro, Ishii, Norio, Nishioka, Hiroko, Horio, Kaori, Furusho, Masatsugu, Ikema, Michiko, Otsu, Kae, Yano, Tomomi, Shirao, Tomohiro, Matsuyama, Rina, Nishiyama, Toshihiko, Matsuyoshi, Akiko, Takeda, Haruo, Kasho, Masaya, Tsutsumi, Etsuro, Ono, Kaoru

“…Aims/Introduction The aim of the present prospective observational study was to assess long‐term efficacy and safety of insulin degludec as a part of a…”
Get full text

A Case of Ectopic Adrenocorticotropic Hormone-producing Pancreatic Neuroendocrine Tumor with Multiple Liver Metastases by KONDO, Tatsuya, MATSUYAMA, Rina, ASHIHARA, Hiroshi, MATSUO, Yasuto, SASAKI, Kazunari, GOTO, Rieko, ONO, Kaoru, TAKAKI, Yuki, HONDA, Yumi, IYAMA, Ken-ichi, KAWASHIMA, Junji, MOTOSHIMA, Hiroyuki, TSURUZOE, Kaku, MIYAMURA, Nobuhiro, ARAKI, Eiichi

“…Ectopic adrenocorticotropic hormone (ACTH) production by the pancreatic neuroendocrine tumor (p-NET) is relatively rare, and patients with this tumor show poor…”
Get full text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naive Japanese adults with type 2 diabetes : a pilot, randomized, controlled study by Seiya Shimoda, Wakana Sakamoto, Ayaka Hokamura, Yasuto Matsuo, Taiji Sekigami, Shinji Ichimori, Shinsuke Iwashita, Norio Ishii, Kae Otsu, Ryohei Yoshimura, Toshihiko Nishiyama, Masaji Sakaguchi, Kenro Nishida, Eiichi Araki

“…Abstract. To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs…”
Get full text

Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy by Seiya Shimoda, Shinsuke Iwashita, Shinji Ichimori, Yasuto Matsuo, Rieko Goto, Takako Maeda, Tomoko Matsuo, Taiji Sekigami, Junji Kawashima, Tatsuya Kondo, Takeshi Matsumura, Hiroyuki Motoshima, Noboru Furukawa, Kenro Nishida, Eiichi Araki

“…[Abstract.] To assess the efficacy and safety of adding sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in subjects with type 2 diabetes inadequately…”
Get full text

Development of a highly responsive needle-type glucose sensor using polyimide for a wearable artificial endocrine pancreas by Ichimori, Shinji, Nishida, Kenro, Shimoda, Seiya, Sekigami, Taiji, Matsuo, Yasuto, Ichinose, Kenshi, Shichiri, Motoaki, Sakakida, Michiharu, Araki, Eiichi

“…To produce a long-life, stable, miniature glucose sensor for a wearable artificial endocrine pancreas (WAEP), we developed a novel microneedle-type glucose…”
Get full text

Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas by Sekigami, Taiji, Shimoda, Seiya, Nishida, Kenro, Matsuo, Yasuto, Ichimori, Shinji, Ichinose, Kenshi, Shichiri, Motoaki, Sakakida, Michiharu, Araki, Eiichi

“…To establish the ideal insulin delivery route for an artificial endocrine pancreas, we examined the effectiveness of closed-loop portal insulin delivery. We…”
Get full text

Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas by Matsuo, Yasuto, Shimoda, Seiya, Sakakida, Michiharu, Nishida, Kenro, Sekigami, Taiji, Ichimori, Shinji, Ichinose, Kenshi, Shichiri, Motoaki, Araki, Eiichi

“…The ultimate goal of the development of an artificial endocrine pancreas is to achieve long-term strict glycemic regulation. To establish the physiological…”
Get full text

A Case of Ectopic Adrenocorticotropic Hormone-producing Pancreatic Neuroendocrine Tumor with Multiple Liver Metastases by TATSUYA KONDO, RINA MATSUYAMA, HIROSHI ASHIHARA, YASUTO MATSUO, KAZUNARI SASAKI, RIEKO GOTO, KAORU ONO, YUKI TAKAKI, YUMI HONDA, KEN-ICHI IYAMA, JUNJI KAWASHIMA, HIROYUKI MOTOSHIMA, KAKU TSURUZOE, NOBUHIRO MIYAMURA, EIICHI ARAKI

“…Abstract. Ectopic adrenocorticotropic hormone (ACTH) production by the pancreatic neuroendocrine tumor (p-NET) is relatively rare, and patients with this tumor…”
Get full text

Relationship Between Canagliflozin, Sodium Glucose Cotransporter 2 Inhibitor, and Hematopoietic Effects in Patients With Diabetes and Mild Heart Failure: Results From the CANDLE Trial by Nakatani, Daisaku, Dohi, Tomoharu, Hikoso, Shungo, Tanaka, Atsushi, Nanasato, Mamoru, Shimizu, Wataru, Node, Koichi, Sakata, Yasushi

“…There were few clinical studies on the relationship between sodium glucose cotransporter 2 inhibitors (SGLT2i) and hematopoiesis in patients with diabetes (DM)…”
Get full text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study by Shimoda, Seiya, Sakamoto, Wakana, Hokamura, Ayaka, Matsuo, Yasuto, Sekigami, Taiji, Ichimori, Shinji, Iwashita, Shinsuke, Ishii, Norio, Otsu, Kae, Yoshimura, Ryohei, Nishiyama, Toshihiko, Sakaguchi, Masaji, Nishida, Kenro, Araki, Eiichi

“…To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs (insulin…”
Get full text

PD-18 - An observational study of diabetes outpatients switching from glargine or detemir to degludec by Sato, Miki, Shimoda, Seiya, Sekigami, Taiji, Motoshima, Hiroyuki, Yoshimura, Ryohei, Fukuda, Kazuki, Matsuo, Yasuto, Okubo, Mina, Ichimori, Shinji, Fujisawa, Kazuo, Araki, Eiichi

Get full text

An observational study of diabetes outpatients switching from glargine or detemir to degludec by Sato, Miki, Shimoda, Seiya, Sekigami, Taiji, Motoshima, Hiroyuki, Yoshimura, Ryohei, Fukuda, Kazuki, Matsuo, Yasuto, Okubo, Mina, Ichimori, Shinji, Fujisawa, Kazuo, Araki, Eiichi

Get full text

Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination by Shimoda, Seiya, Iwashita, Shinsuke, Sekigami, Taiji, Furukawa, Noboru, Matsuo, Yasuto, Ichimori, Shinji, Goto, Rieko, Maeda, Takako, Watanabe, Eiichiro, Kondo, Tatsuya, Matsumura, Takeshi, Motoshima, Hiroyuki, Nishida, Kenro, Araki, Eiichi

“…Aims/Introduction The goal of the study was to examine the effects of sitagliptin dose‐up or glimepiride dose‐up in Japanese patients with type 2 diabetes who…”
Get full text

Comparison of the efficacy of sitagliptin and glimepiride dose‐up in J apanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination by Shimoda, Seiya, Iwashita, Shinsuke, Sekigami, Taiji, Furukawa, Noboru, Matsuo, Yasuto, Ichimori, Shinji, Goto, Rieko, Maeda, Takako, Watanabe, Eiichiro, Kondo, Tatsuya, Matsumura, Takeshi, Motoshima, Hiroyuki, Nishida, Kenro, Araki, Eiichi

“…Aims/IntroductionThe goal of the study was to examine the effects of sitagliptin dose‐up or glimepiride dose‐up in Japanese patients with type 2 diabetes who…”
Get full text

Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes by Ichimori, Shinji, Shimoda, Seiya, Goto, Rieko, Matsuo, Yasuto, Maeda, Takako, Furukawa, Noboru, Kawashima, Junji, Kodama, Shoko, Sekigami, Taiji, Isami, Satoshi, Nishida, Kenro, Araki, Eiichi

“…Aims/Introduction:  Several experimental studies have shown that ezetimibe improves steatosis and insulin resistance in the liver. This suggests that ezetimibe…”
Get full text